Cargando…
New therapeutic strategies for the treatment of male lower urinary tract symptoms
Male lower urinary tract symptoms (LUTS) are prevalent in the general population, especially in those of advanced age, and are characterized by notable diversity in etiology and presentation, and have been proven to cause various degrees of impairment on quality of life. The prostate has traditional...
Autores principales: | Dimitropoulos, Konstantinos, Gravas, Stavros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853157/ https://www.ncbi.nlm.nih.gov/pubmed/27218069 http://dx.doi.org/10.2147/RRU.S63446 |
Ejemplares similares
-
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
por: Dimitropoulos, Konstantinos, et al.
Publicado: (2015) -
Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
por: Gravas, Stavros, et al.
Publicado: (2009) -
Practice Patterns in Diagnosis and Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia among General Practitioners: Lessons Learnt from a Greek Survey
por: Samarinas, Michael, et al.
Publicado: (2018) -
Recent advances in the understanding of male lower urinary tract symptoms (LUTS)
por: Kahokehr, Arman A., et al.
Publicado: (2016) -
The Urinary Tract Microbiome in Male Genitourinary Diseases: Focusing on Benign Prostate Hyperplasia and Lower Urinary Tract Symptoms
por: Kim, Myung Soo, et al.
Publicado: (2021)